Prospective Study of Viral Shedding in Patients with genital HSV-1 and HSV-2 Infection

Prospective Study of Viral Shedding in Patients with genital HSV-1 and HSV-2 Infection - HS01

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012889

Enrollment

Registered

2017-08-14

Start date

2017-08-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A60

Interventions

Group 1: Patients with active genital Herpes who will perform a swab every day for 10 consecutive days and will send them to a virological lab.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Recurrent HSV-1/-2 infection with visible macroscopic lesions (ulcera, bubble, erythema) of urogenital or anal mucosa with known chronic recurring HSV-infection of u / anal tract or urogenital-tract 2) Age = 18 Years 3) Capacity to communicate with the investigator 4) Capacity to consent 5) Capacty of given consent in written form

Exclusion criteria

Exclusion criteria: 1) Any disease or condition that will interfer with the sampling or any medical reason that will hamper the sampling of material according to the investigator. 2) Lack of written informed consent

Design outcomes

Primary

Measure	Time frame
Number of positive and negative swabs each day	—

Secondary

Measure	Time frame
DNA copies per mL in each positive swab Time to first negative swab Time course	—

Countries

Germany

Contacts

Public ContactNicolas Hohmann

Nationales Centrum für Tumorerkrankungen

Herpes.Studie@med.uni-heidelberg.de06221 56-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026